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Abstract: Human herpesvirus-6A and -6B (HHV-6A and -6B) are two closely related 
betaherpesviruses that infect humans. Upon primary infection they establish a life-long infection 
termed latency, where the virus genome is integrated into the telomeres of latently infected cells. 
Intriguingly, HHV-6A/B can integrate into germ cells, leading to individuals with inherited 
chromosomally-integrated HHV-6 (iciHHV-6), who have the HHV-6 genome in every cell. It is 
known that telomeric repeats flanking the virus genome are essential for integration; however, the 
protein factors mediating integration remain enigmatic. We have previously shown that the 
putative viral integrase U94 is not essential for telomere integration; thus, we set out to assess the 
contribution of potential viral recombination proteins U41 and U70 towards integration. We could 
show that U70 enhances dsDNA break repair via a homology-directed mechanism using a reporter 
cell line. We then engineered cells to produce shRNAs targeting both U41 and U70 to inhibit their 
expression during infection. Using these cells in our HHV-6A in vitro integration assay, we could 
show that U41/U70 were dispensable for telomere integration. Furthermore, additional inhibition 
of the cellular recombinase Rad51 suggested that it was also not essential, indicating that other 
cellular and/or viral factors must mediate telomere integration. 
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1. Introduction 
Human herpesvirus 6A and 6B (HHV-6A and 6B) are genetically closely related human 
herpesviruses. Primary infection with HHV-6B occurs in the first years of life and causes the febrile 
illness roseola infantum, which is occasionally accompanied by complications such as seizures and 
encephalitis [1,2]. The disease burden of HHV-6A remains poorly understood and humans appear to 
acquire this infection later in life. Interestingly, a recent study has highlighted a possible association 
between HHV-6A infection and Alzheimer’s disease [3], although more work is required to establish 
the nature of this association. After primary infection, HHV-6A/B establish a quiescent stage of 
infection termed latency. Both viruses have been shown to integrate their genome into the telomeres 
of latently infected cells [4–6]. Intriguingly, HHV-6 is also able to integrate into germ cells and can be 
transmitted vertically, resulting in ~1 % of the world population harboring the virus in every 
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Abstract: Human herpesvirus-6A and -6B (HHV-6A and -6B) are two closely related
betaherpesviruses that infect humans. Upon primary infection they establish a life-long infection
termed latency, where the virus genome is integrated into the telomeres of latently infected
cells. Intriguingly, HHV-6A/B can integrate into germ cells, leading to individuals with inherited
chromosomally-integrated HHV-6 (iciHHV-6), who have the HHV-6 genome in every cell. It is known
that telomeric repeats flanking the virus genome are essential for integration; however, the protein
factors mediating integration remain enigmatic. We have previously shown that the putative viral
integrase U94 is not essential for telomere integration; thus, we set out to assess the contribution of
potential viral recombination proteins U41 and U70 towards integration. We could show that
U70 enhances dsDNA break repair via a homology-directed mechanism using a reporter cell line.
We then engineered cells to produce shRNAs targeting both U41 and U70 to inhibit their expression
during infection. Using these cells in our HHV-6A in vitro integration assay, we could show that
U41/U70 were dispensable for telomere integration. Furthermore, additional inhibition of the cellular
recombinase Rad51 suggested that it was also not essential, indicating that other cellular and/or viral
factors must mediate telomere integration.
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1. Introduction
Human herpesvirus 6A and 6B (HHV-6A and 6B) are genetically closely related human
herpesviruses. Primary infection with HHV-6B occurs in the first years of life and causes the febrile
illness roseola infantum, which is occasionally accompanied by complications such as seizures and
encephalitis [1,2]. The disease burden of HHV-6A remains poorly understood and humans appear to
acquire this infection later in life. Interestingly, a recent study has highlighted a possible association
between HHV-6A infection and Alzheimer’s disease [3], although more work is required to establish
the nature of this association. After primary infection, HHV-6A/B establish a quiescent stage of
infection termed latency. Both viruses have been shown to integrate their genome into the telomeres of
latently infected cells [4–6]. Intriguingly, HHV-6 is also able to integrate into germ cells and can be
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transmitted vertically, resulting in ~ 1% of the world population harboring the virus in every nucleated
cell [4,7–11]. Reactivation of HHV-6 from both the inherited and exogenously acquired forms has been
associated with various severe diseases such as heart disease, graft versus host disease (GVHD),
neuronal disorders and unexplained infertility [12–19].
Telomeric repeats (TMRs) present in the direct repeat regions (DRs) at the end of the virus
genome are essential for efficient integration, suggesting that integration may occur by homologous
recombination (HR) between the host telomeres and viral TMRs [20]. Surprisingly, we recently
demonstrated that a mutant HHV-6A lacking the putative viral integrase (U94) efficiently integrated
into host telomeres [21], suggesting that other viral or cellular factors facilitate the integration process.
Herpes simplex virus 1 (HSV-1) encodes two viral proteins, a single strand DNA-binding protein
(ICP8; UL29) and a 5′-3′exonuclease [UL12], which are involved in recombination of the HSV-1 genome
during replication [22–25]. These genes are highly conserved within the Herpesviridae family and
the HHV-6A/B genomes contain putative orthologues of these two genes (termed U41 and U70,
respectively). As these viral proteins can mediate HSV-1 genome recombination, we hypothesized
that the HHV-6A orthologues could facilitate virus integration. We were able to show that, similar to
HSV-1 UL12, U70 enhances the single strand annealing (SSA) DNA repair pathway. Surprisingly, we
could demonstrate that U70 and U41 were dispensable for HHV-6A telomere integration using cells
expressing potent shRNAs. Moreover, as we utilized our U94-deletion virus, the lack of an effect
on integration was not caused by functional redundancy between U94 and U41/U70. Strikingly,
an additional block of the cellular recombinase Rad51 also did not inhibit telomere integration.
Taken together, our data demonstrate that the HHV-6A integration mechanism is complex and indicate
that other cellular DNA repair pathways and/or other viral proteins must facilitate this process.
2. Materials and Methods
2.1. Cell Culture and Viruses
JJhan cells were maintained in RPMI (PAN Biotech; Aidenbach, Germany) and supplemented with
10% fetal bovine serum (FBS; PAN Biotech) and penicillin/streptomycin. 293T cells were maintained in
DMEM (PAN Biotech) supplemented with 10% FBS, penicillin, streptomycin and 5 µg/mL plasmocin
(InvivoGen; Toulouse, France). HHV-6A U94-deletion GFP reporter virus (HHV-6A ∆U94) was
described previously [21], and was propagated on JJhan cells.
2.2. Plasmid Construction and Lentivirus Production
To generate a lentiviral vector that delivers two shRNAs, we engineered pLKO5.sgRNA.EFS.PAC
(Addgene; #57825). A synthetic construct containing two shRNA cloning sites and the 7SK
promoter were obtained and inserted into the vector between the NdeI and EcoRI restriction sites.
This yielded a vector containing a hU6-promoter-shRNA cloning site and an adjacent, although in the
opposite orientation, 7SK promoter-shRNA cloning site. The shRNAs were generated by annealed
oligonucleotide cloning and the sequences were inserted between the BsmBI sites (shRNA 1) and
BfuAI sites (shRNA 2). The sequences are shown in Table 1.
Target sites were selected using the siRNA Wizard software (https://www.invivogen.com/
sirnawizard/index.php) using the human off-target database to prevent off-targeting effects.
To change the antibiotic resistance gene in the pLKO5.shU41.PAC vector, the hygromycin
resistance gene was amplified (Table 1) and inserted between the BamHI and MluI sites flanking
the puromycin resistance gene.
The expression construct for HHV-6A U70 with a C-terminal HA-tag was produced by PCR
amplification of the U70 coding sequence from the HHV-6A bacterial artificial chromosome (BAC) and
was inserted into the pCMV-mGFP Cterm S11 Neo Kan vector (Sandia BioTech; Albuquerque, NM,
USA) between the XhoI and BamHI sites (pU70-HA-S11). To insert a stop codon before the sequence
coding for the C-terminal HA-tag, Phusion DNA polymerase site-directed mutagenesis (NEB) was
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performed according to the manufacturer’s instructions with the primers listed in Table 1. U41-HA was
created by PCR amplification of the U41 coding region from the HHV-6A BAC and was inserted into
psiCHECK-2 (Promega; Madison, WI, USA) between the NheI and XhoI sites (psiU41-HA), replacing
the Renilla luciferase gene. All primer sequences are shown in Table 1.
Lentiviruses packaging the shRNA vectors were constructed by transfecting 293T cells with
pCMVDR8.91, pCMV-VSV-G and either pLKO5.2XshU41.HPH or pLKO5.2XshU70.PAC. Lentiviruses
were harvested 36 h post-transfection and used for transduction as described previously [26]. After the
transduction of 293T cells with the lentiviruses expressing two shRNAs against U41 and U70 each,
cells were selected with 1 µg/mL puromycin for 5 days, followed by the selection of cells with
hygromycin 400 µg/mL for 7 days. From these polyclonal cells, single cell clones were produced by
limiting dilution in 96 well plates.
Table 1. Oligonucleotide sequences used in this study.













































2.3. 293T Single Strand Annealing (SSA) DNA Repair Reporter
To generate an SSA reporter cell line, we transfected 293T cells with the previously described
hprtSAGFP reporter construct (Addgene; #41594 [27]), selected with 1 µg/mL puromycin for seven
days and single cell clones were generated. The cells were maintained in 0.5 µg/mL puromycin,
post-selection. These cells harbor a construct containing a disrupted GFP coding region that is
separated by an I-SceI restriction site and flanked by homologous sequences that can only be repaired
by SSA DNA-damage repair. Upon successful SSA repair, the GFP coding sequence is restored and GFP
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is expressed. To assess SSA enhancement by viral proteins, cells were PEI-transfected in duplicate with
pCBA-SceI (Addgene; #26477), pE2-Crimson (Clonetech; Mountain View CA, USA) and the expression
vectors: pU70-HA-S11, psiU41-HA, pU70∆HA-tag, pSAKUL12, pSAKUL12-D340E or pcDNA3.1
(mock control; Invitrogen; Carlsbad CA, USA) at a molar ratio of 2:1:1. Three days post-transfection,
the percentage of GFP (successful repair) and Crimson (transfected) positive cells were enumerated by
flow cytometry. Repair was defined as (Crimson+& GFP+)
(Crimson+)+(Crimson+&GFP+) . Mock transfected cells were set to
1 and the other samples were expressed according to the mock for each independent experiment.
2.4. SDS-PAGE and Immunoblotting
Samples for protein analysis were lysed on ice using radioimmunoprecipitation (RIPA) buffers
and benzonase. The samples were boiled, loaded, and separated by SDS-polyacrylamide gel
electrophoresis. Proteins were transferred onto nitrocellulose membrane (Merck Millipore; Burlington,
MA, USA) and blocked with 3% milk in PBS tween. These proteins were indirectly immunoblotted
with anti-HA (1:1000; Cell Signaling; Danvers, MA, USA) and anti-β-actin (1:1000; Cell Signaling)
followed by anti-mouse-HRP (1:10,000; Sigma–Aldrich; St. Louis, MO, USA) and anti-rabbit-HRP
(1:5000; Cell Signaling) respectively. HRP was detected using Amersham ECL Prime (GE Healthcare;
Chicago, IL, USA) using the Chemi-Smart 5100 detection system (PeqLab; Erlangen, Germany).
The band intensity was quantified using BIO-1D v12 software (Vilber; Collegein, France) using the
thresholding algorithm.
2.5. In Vitro HHV-6 Integration Assay
The assay was performed as previously described [20,21]. Briefly, 293T or knockdown cells were
co-cultured with HHV-6A infected JJhans for 4 h. JJhans were then washed away and the following day
the GFP-positive cells sorted on a FACS AriaIII (BD Biosciences; Franklin Lakes, NJ, USA). Immediately
post-sort, a sample was taken for DNA extraction and the remaining cells returned to the culture.
The cells were passaged and 14 days post-sorting, a sample was taken for DNA isolation and another
was prepared for fluorescent in situ hybridization as previously described [20,28,29].
2.6. RT-qPCR Analysis of U70 and U41 Levels during Infection
The cells were infected with equal doses of HHV-6A ∆U94 and the number of infected cells
quantified by flow cytometry 24 h later. The following day, total RNA was extracted from the infected
cells using the RNeasy kit (Qiagen; Venlo, Netherlands) and remaining DNA removed by DNase
treatment (Promega). RNA was converted to cDNA using the Multiscribe reverse transcriptase
(Applied Biosystems; Foster City, CA, USA) according to the manufacturer’s instructions. The qPCR
was performed using the SensiFast master mix (Bioline; Memphis, TN, USA) on 5 µL of cDNA using the
primers and TaqMan probes listed in Table 1. Relative levels of U70 and U41 RNA were normalized to
the level of infection measured by flow cytometry.
2.7. qPCR Analysis
DNA was isolated from samples using the RTP DNA/RNA Virus Mini Kit (Stratec; Edmonton,
AB, Canada) following the manufacturer’s guidelines. The qPCR was performed with FIREpol master
mix (Solis BioDyne; Tartu, Estonia) on 1 µL of isolated DNA using the primers and TaqMan probes
in Table 1. qPCR was performed on an ABI 7500 qPCR machine and analyzed using ABI StepOne
software (Applied Biosystems; Foster City, CA, USA).
2.8. HHV-6A Genome Fluorescent In Situ Hybridization (FISH)
The detection of the HHV-6A genome by fluorescent in situ hybridization (FISH) was performed
as previously described [20,28,29]. However, to enhance the detection of the HHV-6A genome,
the following modifications were applied. After washing off unbound anti-DIG FITC Fab fragments
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(Roche; Basel, Switzerland), cells were stained with a secondary mouse anti-FITC Alexa Fluor 488
antibody (1:200; Merck Millipore) for 20 min followed by the standard washing in detergent buffer
(2× SSC 0.03% tween20). A tertiary anti-mouse Alexa Fluor 488 antibody (1:1000; ThermoFisher;
Waltham, MA, USA) was then added for 20 min followed by washing. Images were acquired with a
100× objective on a Zeiss M1 microscope through Zeiss filters for DAPI and FITC using a metal halide
lamp. The images were then analyzed using ImageJ (https://imagej.nih.gov/ij/).
3. Results
3.1. HHV-6A U41 and U70 in Single Strand Annealing (SSA) DNA Repair
HSV-1 UL12 has been shown to aid the repair of double strand DNA breaks (DSB) via a single
strand annealing mechanism using a DNA damage reporter assay [23]. To test whether HHV-6A
U70, the orthologue of HSV-1 UL12, can also facilitate DSB repairs through SSA, we utilized a
well-established SSA reporter system in 293T cells [27]. The expression of HSV-1 UL12 significantly
increased the SSA DNA repair that was abolished, by mutating the active site of the exonuclease
(Figure 1), as previously reported [23]. Interestingly, HHV-6A U70 also enhanced DSB repair through
the SSA pathway (Figure 1A). Furthermore, the removal of the C-terminal HA-tag on U70 increased
its ability to aid SSA repair, suggesting that the tagging of U70 interferes with its activity (Figure 1B).
The expression of HHV-6A U41 neither enhanced SSA repair nor augmented the effect of U70
(Figure 1A). Taken together, these data suggest that HHV-6A U70 can aid in the repair of homologous
DNA sequences via the SSA pathway.
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Figure 1. The role of HHV-6A U70 and U41 in double strand DNA break repair by single strand 
annealing (SSA). (A) An SSA reporter was integrated into 293T cells and the cells were transfected 
with the indicated expression plasmids. The frequency of repair was calculated and normalized to 
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transfected construct (n = 3 ± SEM). (B) The C-terminal HA-tag on U70 was removed and the same 
assay as in (A) was performed (n = 3 ± SEM). 
3.2. Generation of a U41 and U70 Knockdown Cell Line 
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a eali g (SS ). (A) An SSA reporter was integrated into 293T cells and the cells were transfected with
the indicated expression plasmids. The frequency of repair was calculated and normalized to the mock
transfected cells (control plasmid). Displayed are the mean frequency of repair for each transfected
construct (n = 3 ± SEM). (B) The C-terminal HA-tag on U70 was removed and the same assay as in (A)
was performed (n = 3 ± SEM).
3.2. Generation of a U41 and U70 Knockdown Cell Line
To determine if U70 and/or U41 are involved in HHV-6 integration, we set out to assess the
integration efficiency upon the knockdown of both proteins. As UL12 and UL29 play a crucial role
in HSV-1 replication [30–32], we generated target cells for our integration assay that express four
shRNAs, two each against U41 and U70. Cells were selected after lentiviral delivery of the shRNAs
against U41/U70 and the knockdown confirmed by Western blotting in the cells transfected with
HA-tagged U41 or U70 expression plasmids. Polyclonal U41/U70 knockdown cells (Kd poly) displayed
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a robust knockdown of U41-HA and U70-HA compared to the parental 293T cells (Figure 2A), despite
the high-level plasmid-driven overexpression of these viral genes. To achieve an almost complete
knockdown, clones were isolated and tested for their knockdown efficiency as stated above (Figure 2A).
Clone 5 (Kd C5) had the most efficient knockdown of both U41-HA and U70-HA (0.54% and 0.16%
levels seen in 293T control, respectively) and was also included in our integration assay (Figure 2B).
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plasmids. One day post-tr nsfec ion, cells were ysed and the pro eins separated by SDS-PAGE.
Immunoblotti g was then performed using anti-HA or anti-beta-actin (beta-actin; lo ding c ntrol)
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for protein loading (β-actin). Displayed in the histogram is he viral prote n expression in the poly
clonal cells (Kd po y) and the best clonal cell (Kd C5) relative to expressi n in 293T control cells.
In order to ensure that this U41/U70 knockdown was effective upon virus infection we assessed
the levels of U41 and U70 RNA in knockdown cells infected with HHV-6A ∆U94. Both U41 nd U70
RNA l vels were re uced in both Kd cell lines (Figure S1). Taken together, these results suggest that
the knockdo n cells inhibit the expression of U41 and U70, even in the context of infection.
3.3. Effect of U41/U70 Knockdown on HHV-6 Integration
To assess the integration efficiency upon the knockdown of U41/U70, we used our HHV-6A
integration assay as previously described [20,21]. We have previously shown that HHV-6A can
efficiently integrate in the absence of the putative virus integrase (U94) [21]. However, since U94 was
still able to compensate for the loss of U41/U70, we used our U94-deletion HHV-6A virus (HHV-6A
∆U94) to assess the integration in the U41/U70 knockdown cells.
293T or Kd poly cells were infected, cultured over-night and sorted to obtain a pure
GFP-positive-infected population. Samples were taken post-sort and 14 days later to quantify the
virus genome maintenance within the culture. After sorting, virus DNA levels were comparable for
all samples (Figure 3A). Strikingly, the virus genome maintenance over time was not altered upon
the knockdown of U41/U70, suggesting that the expression of both proteins was not essential for the
HHV-6A maintenance in cell culture. To determine if the cellular recombinase Rad51 can complement
for the loss of U41, U70 and U94, we also inhibited Rad51 using a small molecule inhibitor. However,
HHV-6A was still efficiently maintained in the absence of all three viral proteins and activity of the
cellular recombinase (Figure 3A). To confirm the integration of the HHV-6A genome at the ends of host
chromosomes, we performed fluorescent in situ hybridization (FISH). HHV-6A was readily detected
at chromosome ends in the absence of all three viral proteins and inhibition of the cellular recombinase
Rad51 (Figure 3B), indicating that all four proteins were dispensable for HHV-6A integration.
To confirm that the observed phenotype in the Kd poly cells was not due to some cells within the
population with a partial knockdown phenotype (Figure 2A), we performed the same integration assay
with Kd C5. As observed for the Kd poly cells, the knockdown of U41/U70 did not inhibit HHV-6A
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genome maintenance even in the absence of U94 (Figure 4). Taken together, our data demonstrate that
the viral proteins U41, U70 and U94, as well as the cellular recombinase Rad51 are dispensable for
HHV-6A integration.
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HHV-6A and -6B have been shown to integrate their genome into the host chromosomes of
latently infected cells. We have recently shown that the viral telomere sequences are vital for this
integration process; however, the protein counterparts remain unknown. It had been proposed that
the putative integrase U94 facilitates integration based on the fact that it interacts with telomere
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DNA, possesses the enzymatic activities necessary to mediate recombination and could facilitate
the replication of adeno-associated virus 2 (AAV-2) lacking its Rep68 integrase [33,34]. However,
we recently demonstrated that HHV-6A lacking U94 efficiently integrated into host chromosomes
in vitro [21]. Multiple possibilities exist as to how the virus could integrate in the absence of U94:
(i) U94 is not the viral integrase (ii) redundant pathways exist for telomere integration or (iii) the
integration pathway in vivo differs from the one utilized in vitro. In this study we set out to address
(i) and (ii) by targeting the HHV-6A proteins U41/U70 that could potentially facilitate integration in
the absence of U94.
U41 and U70 are the orthologues of UL29 and UL12 from HSV-1 that encode a single strand DNA
binding protein (UL29) and a 5′-3′ exonuclease (UL12), respectively. These genes are highly conserved
for the Herpesviridae and have been shown to facilitate the recombination of the HSV-1 genome
via the SSA DNA repair pathway [23–25]. Since all available data suggest that HHV-6 integrates by
recombination between the viral and host telomeres, U41/U70 could potentially be involved in this
process by augmenting SSA.
We could demonstrate that U70 enhances the SSA DNA repair pathway using a well-established
reporter system (Figure 1), although the magnitude of the effect was smaller than that seen with HSV-1
UL12 [23]. Interestingly, the removal of the C-terminal HA-tag on U70 showed that the tag impaired
U70 function. However, the activity of U70 in SSA remained weaker than its counterpart from HSV-1
(Figure 1B).
Intriguingly, we were able to demonstrate that HHV-6A efficiently integrated upon the
knockdown of U41/U70 (Figures 3 and 4). This was shown using HHV-6A lacking U94 to ensure that
it did not substitute for the loss of U41/U70 expression. The additional inhibition of homologous
recombination (HR) using RI-1 did not significantly reduce the ability of HHV-6A to integrate into
host chromosomes (Figure 3), indicating that it does not compensate for the loss of these three viral
factors. Taken together, our data shows that HHV-6A U70 can aid in SSA DNA repair but U41/U70
are dispensable for HHV-6A integration and do not compensate for the loss of U94 or cellular HR
DNA repair.
Although we demonstrated that the most likely viral candidates and HR are dispensable for
HHV-6A integration, the factors that facilitate this process still remain unknown. Cells possess more
than one pathway that can mediate a recombination and repair breaks in the genome. Some of these
pathways are specialized in the repair of homologous DNA sequences and we will investigate if these
pathways are involved in HHV-6 integration in future studies. The delineation of the factors involved
in HHV-6 integration will uncover the integration mechanism and unveil the process that permitted
this virus to enter the human germ line.
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/10/11/656/
s1,Figure S1: U41 & U70 mRNA levels in knockdown cells.
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